RDY

NYSE Dr. Reddy's Laboratories Ltd. Sponsored ADR
Sep 30, 2026 · 5:57 AM ET LAST TRADE Market Closed

$12.80 ↓ -0.05 (-0.39%) Trading Down from the previous close of $12.85

YTD change
-8.83%
vs 20-day SMA
+5.57%
vs 200-day SMA
-3.86%

Price ranges

Previous day
$12.74 $12.99
open $12.91 close $12.85
-$0.06 (-0.46%)
Today
$0.00 $0.00
$12.80
Past week
$12.17 $12.99
from $12.57 now $12.80
+$0.23 (+1.83%)
Past month
$11.51 $12.99
from $12.13 now $12.80
+$0.67 (+5.52%)
This year
$11.36 $15.67
from $14.04 now $12.80
-$1.24 (-8.83%)

Price & Performance

-0.61 (-4.53%) / 6M

$11.06$12.61$14.15$15.70Mar 30Jun 30Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 24.2% away from all-time highs of $16.89
  • RDY is down 9% since the beginning of the year
  • RDY is down 8% over the past 12 months
  • RDY is up 6% over the past 1 month
  • 3% of all RDY investors are betting against RDY
  • Number of investors short RDY has gone up 39% versus last month

RDY reads neutral: price sits above one of the two key moving averages, short interest is rising month over month, the 12-month move is -8.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.055191
Earnings momentum +43.7% Quarterly EPS growth
Quarterly change +43.7%

Valuation

P/E ratio 29.17
Enterprise value $10.4B
Beta 0.08

Balance sheet & scale

Income$366.1K
Revenue$3.7B
Cash$860.2M
Debt$760.1K
Income / Debt 0.48×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $10.7B

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment refers to the manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,184.63 -0.01%
JNJ Johnson & Johnson $267.57 -1.61%
ABBV AbbVie, Inc. $263.29 -1.12%
MRK Merck & Co., Inc. $149.28 +0.40%
RHHVF Roche Holding Ltd $431.56 -2.94%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.